A type of drug known as a PARP inhibitor, already used to treat breast and ovarian cancer, may be useful in treating children with high-risk neuroblastoma—a common childhood tumor with a low survival rate. Neuroblastoma is a cancer in children…
Read MoreBreakthrough technology used to discover eye damage from repeated intravitreal injections
In a first of its kind study, Mount Sinai researchers are using optimal coherence tomography angiography (OCTA) to measure potential retina damage from long-term use of intravitreal eye injections. The findings, published in the April issue of Retina, suggest that…
Read MoreItaly’s coronavirus ‘red zone’ gets used to life under quarantine
At the edge of the northern Italian town of Casalpusterlungo, residents are slowly getting used to the isolation measures descending around towns like theirs, the centres of Italy’s outbreak of the new coronavirus. Here the frontline of the fight against…
Read MoreInduced pluripotent stem cells used to regulate immune reaction to transplanted tissues
Scientists suggest a new strategy that uses induced pluripotent stem cells (iPSCs) to regulate immune reaction to transplanted tissues. The team, led by Professor Ken-ichiro Seino of Hokkaido University’s Institute for Genetic Medicine, found that thymic epithelium cells derived from…
Read More